Neuralink Raises $650M as Clinical Trials Commence for Brain Implant Technology

Fremont, CA, June 2, 2025 (Reuters) -- Elon Musk’s Neuralink has raised $650 million to support the advancement of its brain implant technology, which has now entered clinical trials in three countries. The device allows patients with severe paralysis to control devices through neural signals, marking significant progress in neurotechnology. With FDA “breakthrough” designations for its speech and vision restoration devices, Neuralink is accelerating its development to address unmet medical needs and expand brain-computer interface capabilities.

Read full article here.